Sagimet Biosciences Inc (SGMT)
4.44
+0.35
(+8.56%)
USD |
NASDAQ |
May 02, 16:00
4.44
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences Cash from Investing (TTM): 12.58M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 12.58M |
September 30, 2023 | 37.64M |
June 30, 2023 | 41.64M |
Date | Value |
---|---|
March 31, 2023 | -12.61M |
December 31, 2022 | -32.01M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-32.01M
Minimum
Dec 2022
41.64M
Maximum
Jun 2023
9.446M
Average
12.58M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
Madrigal Pharmaceuticals Inc | -502.52M |
89bio Inc | -123.02M |
Viking Therapeutics Inc | -641.08M |
Akero Therapeutics Inc | -223.62M |
Arrowhead Pharmaceuticals Inc | 49.38M |